Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids.
Continuous Reaction Time (CRT) was measured in cancer patients receiving peripherally acting analgesics either alone (n = 16) or in combination with opioids (n = 16). Comparison was performed matching the patients from each group for age and performance status. Statistically significant prolongations of CRT and higher sedation scores were seen in the opioid group, while performance status did not have any influence on CRT.
Banning
A
A
Pain Clinic, Finsen Institute, Rigshospitalet, Copenhagen, Denmark.
Sjøgren
P
P
Kaiser
F
F
D000082:Acetaminophen / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D004091:Hydromorphone / Q000627:therapeutic use; D008297:Male; D008614:Meperidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D009020:Morphine / Q000627:therapeutic use; D009022:Morphine Derivatives / Q000627:therapeutic use; D009369:Neoplasms / Q000503:physiopathology*; D009539:Nicotinic Acids / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000209:etiology
D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009022:Morphine Derivatives; D009539:Nicotinic Acids; D000082:Acetaminophen; D009020:Morphine; D008614:Meperidine; C012394:ketobemidone; D004091:Hydromorphone; C008549:nicomorphine